Assessment of Insulin Sensitivity from Steady-State and Dynamic Tests

Clinical Diabetes Research: Methods and Techniques

Volumn , Issue , 2007, Pages 27-41

  Pacini, Giovanni ^a   Mari, Andrea ^a  

^a CNR   (Italy)

Author keywords

Glucose utilisation rate; Hepatic glucose production; Hyperglycaemia and hyperinsulinaemia; Impaired insulin action; Insulin suppression test; Insulin glucose homeostatic process; Oral glucose load; Stimulated counterregulatory hormones

Indexed keywords

GLUCOSE;

DYNAMIC TESTS; GLUCOSE PRODUCTION; HOMEOSTATIC PROCESS; HYPERGLYCAEMIA; INSULIN ACTION; INSULIN SENSITIVITY; STEADY STATE;

INSULIN;

EID: 84889486849     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470513095.ch3     Document Type: Chapter

References (52)

1. Amatuzio DS, Stutzman FL, Vanderbilt MJ, Nesbitt S (1953) Interpretation of the rapid intravenous glucose tolerance test in normal individuals and in mild diabetes mellitus J Clin Invest 32, 428-435.
2. Baron AD, Kolterman OG, Bell J, Mandarino LJ, Olefsky JM (1985) Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects J Clin Invest 76, 1782-1788.
3. Beard JC, Bergman RN, Ward WK, Porte D Jr (1986) The insulin sensitivity index in nondiabetic man: Correlation between clamp-derived and IVGTT-derived values Diabetes 35, 362-369.
4. Bergman RN (1989) Toward physiological understanding of glucose tolerance: Minimal-model approach Diabetes 38, 1512-1527.
5. Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo Endocrine Reviews 6, 45-86.
6. Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of insulin sensitivity Am J Physiol Endocrinol Metab 236, E667-E677.
7. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man J Clin Invest 68, 1456-1467.
8. Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp J Clin Invest 79, 790-800.
9. Berson SA, Yalow RS (1970) Insulin 'antagonists' and insulin resistance In: M Ellenberg, H Rifkin (Eds) Diabetes Mellitus: Theory and Practice, McGraw-Hill, New York, pp 388-423.
10. Best JD, Kahn SE, Ader M et al. (1996) Role of glucose effectiveness in the determination of glucose tolerance Diabetes Care 19, 1018-1030.
11. Bonora E, Moghetti P, Zancanaro C et al. (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies J Clin Endocrinol Metab 68, 374-378.
12. Boston RC, Stefanovski D, Moate PJ et al. (2003) MINMOD millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test Diabetes Technol Ther 5, 1003-1015.
13. Brehm A, Thomaseth K, Bernroider E et al. (2006) The role of endocrine counterregulation for estimating insulin sensitivity from intravenous glucose tolerance tests J Clin Endrocrinol Metab 91, 2272-2278.
14. Caumo A, Vicini P, Cobelli C (1996) Is the minimal model too minimal? Diabetologia 39, 997-1000.
15. DeFronzo RA, Ferrannini E, Keen H, Zimmet P (Eds) (2004) International Textbook of Diabetes Mellitus, Wiley, Chichester.
16. Ekberg K, Landau BR, Wajngot A et al. (1999) Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting Diabetes 48, 292-298.
17. Ferrannini E, Mari A (1998) How to measure insulin sensitivity J Hypertens 16, 895-906.
18. Finegood DT (1997) Application of the minimal model of glucose kinetics In: RN Bergman, JC Lovejoy (Eds) The Minimal Model Approach and Determinants of Glucose Tolerance, Louisiana State Univ Press, Baton Rouge, LA, pp. 51-122.
19. Gelding SV, Robinson S, Lowe S, Niththyananthan R, Johnston DG (1994) Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity Clin Endocrinol (Oxf) 40, 611-615.
20. Gibaldi M, Perrier D (1982) Pharmacokinetics (2 ed) Dekker, New York.
21. Godsland IF, Walton C (2001) Maximizing the success rate of minimal model insulin sensitivity measurement in humans: the importance of basal glucose levels Clin Sci (Lond) 101, 1-9.
22. Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G (1981) Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp Diabetes 30, 387-392.
23. Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven G (2000) Roles of insulin resistance and obesity in regulation of plasma insulin concentration Am J Physiol Endocrinol Metab 278, E501-E508.
24. Jones CN, Pei D, Staris P et al. (1997) Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals J Clin Endocrinol Metab 82, 1834-1838.
25. Katz A, Nambi SS, Mather K et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85, 2402-2410.
26. Krentz A (2002) Insulin Resistance Blackwell, Oxford.
27. Lerner RL, Porte D Jr (1971) Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate J Clin Endocrinol Metab 33, 409-417.
28. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program Diabetes Care 21, 2191-2192.
29. Mari A (1997) Assessment ofinsulin sensitivity with minimal model: role of model assumptions Am J Physiol Endocrinol Metab 272, E925-E934.
30. Mari A (2006) Methods of assessment of insulin sensitivity and beta-cell function Immun Endoc & Metab Agents-Med Chem 6, 91-104.
31. Mari A, Ahrén B, Pacini G (2005a) Assessment of insulin secretion in relation to insulin resistance Curr Opin Clin Nutr Metab Care 8, 529-533.
32. Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E (2005b) Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide Diabetes Care 28, 1132-1138.
33. Mari A, Pacini G, Brazzale AR, Ahrén B (2005c) Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test Diabetologia 48, 748-751.
34. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test Diabetes Care 24, 539-548.
35. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing Comparison with the euglycemic insulin clamp Diabetes Care 22, 1462-1470.
36. Matthews DR, Hosker JP, Rudenski AS et al. (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28, 412-419.
37. Moller DE (Ed) (1993) Insulin Resistance, Wiley, Chichester.
38. Pacini G, Bergman RN (1986) MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from frequently sampled IVGTT Comp Methods Programs Biomed 23, 113-122.
39. Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta-cell function Best Pract Res Clin Endocrinol Metab 17, 305-322.
40. Pacini G, Tonolo G, Sambataro M et al. (1998) Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT Am J Physiol Endocrinol Metab 274, E592-599.
41. Porte D Jr, Sherwin RS, Baron A (Eds) (2003) Ellenberg and Rifkin's Diabetes Mellitus, McGraw-Hill, New York.
42. Reaven G, Miller R (1968) Study of the relationship between glucose and insulin responses to an oral glucose load in man Diabetes 17, 560-569.
43. Reaven GM, Laws A (1999) Insulin Resistance-The Metabolic Syndrome X Humana Press, Totowa, NJ.
44. Saad MF, Anderson RL, Laws A et al. (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance Insulin Resistance Atherosclerosis Study Diabetes 43, 1114-1121.
45. Steil GM, Murray J, Bergman RN, Buchanan TA (1994) Repeatability of insulin sensitivity and glucose effectiveness from the minimal model Implications for study design Diabetes 43, 1365-1371.
46. Steil GM, Vølund A, Kahn SE, Bergman RN (1993) Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model Suitability for use in population studies Diabetes 42, 250-256.
47. Stumvoll M, Mitrakou A, Pimenta W et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity Diabetes Care 23, 295-301.
48. Stumvoll M, Van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times Diabetes Care 24, 796-797.
49. Vicini P, Zachwieja JJ, Yarasheski KE et al. (1999) Glucose production during an IVGTT by decon-volution: Validation with the tracer-to-tracee clamp technique Am J Physiol Endocrinol Metab 276, E285-E294.
50. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling Diabetes Care 27, 1487-1495.
51. Wolfe RR (1992) Radioactive and Stable Isotope Tracers in Biomedicine Wiley, New York.
52. Yang YJ, Youn JH, Bergman RN (1987) Modified protocols improve insulin sensitivity estimation using the minimal model Am J Physiol Endocrinol Metab 253, E595-E602.